Sino-Argi Leading Biosciences (603970) — Cash Flow Reinvestment Rate
Sino-Argi Leading Biosciences (603970) has a Cash Flow Reinvestment Rate of 0.79x as of December 2024, reinvesting CN¥555.63 Million (capex CN¥139.59K plus investments CN¥-555.49 Million) from operating cash flow of CN¥702.54 Million. Explore 603970 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sino-Argi Leading Biosciences Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Sino-Argi Leading Biosciences across 10 annual periods. Also explore Sino-Argi Leading Biosciences asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sino-Argi Leading Biosciences (2012–2024)
Year-by-year capital reinvestment analysis for Sino-Argi Leading Biosciences. For live market cap and broader valuation context, see Sino-Argi Leading Biosciences market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.66x | CN¥204.14 Million | CN¥307.40 Million | CN¥2.18 Million | ▲ +76.9% |
| 2022 | 0.38x | CN¥576.44 Million | CN¥1.54 Billion | CN¥3.44 Million | ▲ +190.9% |
| 2021 | 0.13x | CN¥42.00 Million | CN¥325.42 Million | CN¥3.99 Million | ▼ -85.6% |
| 2020 | 0.90x | CN¥315.99 Million | CN¥352.12 Million | CN¥14.99 Million | ▲ +2409.1% |
| 2019 | 0.04x | CN¥7.83 Million | CN¥218.90 Million | CN¥2.67 Million | ▼ -90.3% |
| 2018 | 0.37x | CN¥24.18 Million | CN¥65.69 Million | CN¥8.99 Million | ▼ -18.9% |
| 2017 | 0.45x | CN¥235.35 Million | CN¥518.83 Million | CN¥55.39 Million | ▲ +56.3% |
| 2016 | 0.29x | CN¥44.17 Million | CN¥152.22 Million | CN¥36.85 Million | ▲ +90.0% |
| 2014 | 0.15x | CN¥6.17 Million | CN¥40.41 Million | CN¥6.17 Million | ▲ +862.2% |
| 2012 | 0.02x | CN¥1.74 Million | CN¥109.43 Million | CN¥1.74 Million | — |